Nanodentistry: Combining nanostructured materials and stem cells for dental tissue regeneration

Nanomedicine

Volumn 7, Issue 11, 2012, Pages 1743-1753

  Mitsiadis, Thimios A ^a   Woloszyk, Anna ^a   Jiménez Rojo, Lucia ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

dentin; dentistry; nanomaterials; nanotechnology; odontoblast; periodontium; regenerative medicine; scaffolds; stem cells; tooth

Indexed keywords

NANOMATERIAL; NANOPARTICLE; QUANTUM DOT;

BIOMIMETICS; CELL DIFFERENTIATION; CELL FATE; CELL POPULATION; CLINICAL EFFECTIVENESS; DRUG DELIVERY SYSTEM; GENOMICS; HUMAN; NANODENTISTRY; NANOMEDICINE; NONHUMAN; PATIENT SAFETY; PERIODONTITIS; PRIORITY JOURNAL; PROTEOMICS; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TOOTH; TOOTH DISEASE;

ANIMALS; HUMANS; NANOMEDICINE; NANOSTRUCTURES; REGENERATION; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TOOTH;

EID: 84870598829     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.146     Document Type: Review

References (112)

1. Jiménez-Rojo L, Granchi Z, Graf D, Mitsiadis TA. Stem cell fate determination during development and regeneration of ectodermal organs. Front. Physiol. 3, 107 (2012).
2. Mitsiadis TA, De Bari C, About I. Apoptosis in developmental and repair-related human tooth remodeling: a view from the inside. Exp. Cell Res. 314(4), 869-877 (2008).
3. Caton J, Bostanci N, Remboutsika E, De Bari C, Mitsiadis TA. Future dentistry: cell therapy meets tooth and periodontal repair and regeneration. J. Cell. Mol. Med. 15 (5), 1054-1065 (2011).
4. Mitsiadis TA, Papagerakis P. Regenerated teeth: the future of tooth replacement? Regen. Med. 6(2), 135-139 (2011).
5. Mitsiadis TA, Feki A, Papaccio G, Caton J. Dental pulp stem cells, niches, and notch signaling in tooth injury. Adv. Dental Res. 23(3), 275-279 (2011).
6. Toma JG, Akhavan M, Fernandes KJ et al. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat. Cell Biol. 3(9), 778-784 (2001).
7. Zuk PA, Zhu M, Ashjian P et al. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13(12), 4279-4295 (2002).
8. De Bari C, Dell'accio F, Luyten FP. Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum. 44(1), 85-95 (2001).
9. Alsalameh S, Amin R, Gemba T, Lotz M. Identifcation of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum. 50 (5), 1522-1532 (2004).
10. Miura M, Gronthos S, Zhao M et al. SHED: stem cells from human exfoliated deciduous teeth. Proc. Natl Acad. Sci. USA 100 (10), 5807-5812 (2003).
11. Sonoyama W, Liu Y, Fang D et al. Mesenchymal stem cell-mediated functional tooth regeneration in swine. PLoS ONE 1, e79 (2006).
12. Sonoyama W, Liu Y, Yamaza T et al. Characterization of the apical papilla and its residing stem cells from human immature permanent teeth: a pilot study. J. Endodontics 34(2), 166-171 (2008).
13. Morsczeck C, Gotz W, Schierholz J et al. Isolation of precursor cells (PCs) from human dental follicle of wisdom teeth. Matrix Biol. 24(2), 155-165 (2005).
14. Seo BM, Miura M, Gronthos S et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 364(9429), 149-155 (2004).
15. Wang L, Shen H, Zheng W et al. Characterization of stem cells from alveolar periodontal ligament. Tissue Eng. Part A 17(7-8), 1015-1026 (2011).
16. Gronthos S, Brahim J, Li W et al. Stem cell properties of human dental pulp stem cells. J. Dental Res. 81(8), 531-535 (2002).
17. Huang GT, Yamaza T, Shea LD et al. Stem/progenitor cell-mediated de novo regeneration of dental pulp with newly deposited continuous layer of dentin in an in vivo model. Tissue Eng. Part A 16(2), 605-615 (2010).
18. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl Acad. Sci. USA 97(25), 13625-13630 (2000).
19. About I, Bottero MJ, De Denato P, Camps J, Franquin JC, Mitsiadis TA. Human dentin production in vitro. Exp. Cell Res. 258(1), 33-41 (2000).
20. Alliot-Licht B, Bluteau G, Magne D et al. Dexamethasone stimulates differentiation of odontoblast-like cells in human dental pulp cultures. Cell Tissue Res. 321(3), 391-400 (2005).
21. Tecles O, Laurent P, Zygouritsas S et al. Activation of human dental pulp progenitor/stem cells in response to odontoblast injury. Arch. Oral Biol. 50(2), 103-108 (2005).
22. Waddington RJ, Youde SJ, Lee CP, Sloan AJ. Isolation of distinct progenitor stem cell populations from dental pulp. Cells Tissues Organs 189(1-4), 268-274 (2009).
23. De Mendonca Costa A, Bueno DF, Martins MT et al. Reconstruction of large cranial defects in nonimmunosuppressed experimental design with human dental pulp stem cells. J. Craniofac. Surg. 19 (1), 204-210 (2008).
24. Kerkis I, Ambrosio CE, Kerkis A et al. Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: local or systemic? J. Transl Med. 6, 35 (2008).
25. Nosrat IV, Widenfalk J, Olson L, Nosrat CA. Dental pulp cells produce neurotrophic factors, interact with trigeminal neurons in vitro, and rescue motoneurons after spinal cord injury. Dev. Biol. 238(1), 120-132 (2001).
26. Honda MJ, Shinohara Y, Hata KI, Ueda M. Subcultured odontogenic epithelial cells in combination with dental mesenchymal cells produce enamel-dentin-like complex structures. Cell Transplant. 16 (8), 833-847 (2007).
27. Nam H, Lee G. Identifcation of novel epithelial stem cell-like cells in human deciduous dental pulp. Biochem. Biophys. Res. Comm. 386(1), 135-139 (2009).
28. Nam H, Kim J, Park J et al. Expression profle of the stem cell markers in human Hertwig's epithelial root sheath/epithelial rests of Malassez cells. Mol. Cells 31(4), 355-360 (2011).
29. Shinmura Y, Tsuchiya S, Hata K, Honda MJ. Quiescent epithelial cell rests of Malassez can differentiate into ameloblast-like cells. J. Cell Physiol. 217(3), 728-738 (2008).
30. Atari M, Gil-Recio C, Fabregat M et al. Dental pulp of the third molar: a new source of pluripotent-like stem cells. J. Cell Sci. 125(Pt 14), 3343-3356 (2012).
31. Huang GT, Shagramanova K, Chan SW. Formation of odontoblast-like cells from cultured human dental pulp cells on dentin in vitro. J. Endodontics 32(11), 1066-1073 (2006).
32. Volponi AA, Pang Y, Sharpe P T. Stem cell-based biological tooth repair and regeneration. Trends Cell Biol. 20(12), 715-722 (2010).
33. Washio K, Iwata T, Mizutani M et al. Assessment of cell sheets derived from human periodontal ligament cells: a pre-clinical study. Cell Tissue Res. 341(3), 397-404 (2010).
34. Yang B, Chen G, Li J et al. Tooth root regeneration using dental follicle cell sheets in combination with a dentin matrix-based scaffold. Biomaterials 33(8), 2449-2461 (2012).
35. Howell TH, Fiorellini JP, Paquette DW, Offenbacher S, Giannobile W V, Lynch SE. A Phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J. Periodontol. 68(12), 1186-1193 (1997).
36. Lynch SE, Williams RC, Polson AM et al. A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. J. Clin. Periodontol. 16(8), 545-548 (1989).
37. Nakashima M, Mizunuma K, Murakami T, Akamine A. Induction of dental pulp stem cell differentiation into odontoblasts by electroporation-mediated gene delivery of growth/differentiation factor 11 (Gdf11). Gene Ther. 9 (12), 814-818 (2002).
38. Jin QM, Anusaksathien O, Webb SA, Rutherford RB, Giannobile W V. Gene therapy of bone morphogenetic protein for periodontal tissue engineering. J. Periodontol. 74(2), 202-213 (2003).
39. Ripamonti U, Crooks J, Petit JC, Rueger DC. Periodontal tissue regeneration by combined applications of recombinant human osteogenic protein-1 and bone morphogenetic protein-a pilot study in Chacma baboons (Papio ursinus). Eur. J. Oral Sci. 109(4), 241-248 (2001).
40. Veis A, Tompkins K, Alvares K et al. Specifc amelogenin gene splice products have signaling effects on cells in culture and in implants in vivo. J. Biol. Chem. 275(52), 41263-41272 (2000).
41. Grad I, Hibaoui Y, Jaconi M et al. NANOG priming before full reprogramming may generate germ cell tumours. Eur. Cells Mater. 22, 258-274; discussion 274 (2011).
42. Forsberg M, Hovatta O. Challenges for the therapeutic use of pluripotent stem derived cells. Front. Physiol. 3, 19 (2012).
43. Wada N, Menicanin D, Shi S, Bartold PM, Gronthos S. Immunomodulatory properties of human periodontal ligament stem cells. J. Cell Physiol. 219 (3), 667-676 (2009).
44. Le Blanc K, Ringden O. Immunomodulation by mesenchymal stem cells and clinical experience. J. Inter. Med. 262(5), 509-525 (2007).
45. Wang M, Yang Y, Yang D et al. The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 126(2), 220-232 (2009).
46. Davies LC, Lonnies H, Locke M et al. Oral mucosal progenitor cells are potently immunosuppressive in a dose-independent manner. Stem Cells Dev. 21(9), 1478-1487 (2012).
47. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fbroblast cultures by defned factors. Cell 126(4), 663-676 (2006).
48. Takahashi K, Okita K, Nakagawa M, Yamanaka S. Induction of pluripotent stem cells from fbroblast cultures. Nat. Protocols 2(12), 3081-3089 (2007).
49. Otsu K, Kishigami R, Oikawa-Sasaki A et al. Differentiation of induced pluripotent stem cells into dental mesenchymal cells. Stem Cells Dev. 21(7), 1156-1164 (2012).
50. Li SC, Zhong JF. Twisting immune responses for allogeneic stem cell therapy. World J. Stem Cells 1(1), 30-35 (2009).
51. Okita K, Yamanaka S. Induced pluripotent stem cells: opportunities and challenges. Philos. Trans. R. Soc. Lond. Series B Biol. Sci. 366(1575), 2198-2207 (2011).
52. Zhao T, Zhang ZN, Rong Z, Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 474 (7350), 212-215 (2011).
53. Kim BY, Rutka JT, Chan WC. Nanomedicine. N. Engl. J. Med. 363(25), 2434-2443 (2010).
54. Xia Y. Nanomaterials at work in biomedical research. Nat. Mater. 7(10), 758-760 (2008).
55. Huebsch N, Mooney DJ. Inspiration and application in the evolution of biomaterials. Nature 462(7272), 426-432 (2009).
56. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. FASEB J. 19(3), 311-330 (2005).
57. Moghimi SM, Hunter AC, Andresen TL. Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. Ann. Rev. Pharm. Toxicol. 52, 481-503 (2012).
58. Wang Y, Brown P, Xia Y. Nanomedicine: swarming towards the target. Nat. Mater. 10(7), 482-483 (2011).
59. Petros RA, Desimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 9(8), 615-627 (2010).
60. Von Maltzahn G, Park JH, Lin KY et al. Nanoparticles that communicate in vivo to amplify tumour targeting. Nat. Mater. 10 (7), 545-552 (2011).
61. Douglas SM, Bachelet I, Church GM. A logic-gated nanorobot for targeted transport of molecular payloads. Science 335(6070), 831-834 (2012).
62. Oh S, Brammer KS, Li YS et al. Stem cell fate dictated solely by altered nanotube dimension. Proc. Natl Acad. Sci. USA 106(7), 2130-2135 (2009).
63. Jungebluth P, Alici E, Baiguera S et al. Tracheobronchial transplantation with a stem-cell-seeded bioartifcial nanocomposite: a proof-of-concept study. Lancet 378(9808), 1997-2004 (2011).
64. Andon FT, Fadeel B. Programmed cell death: molecular mechanisms and implications for safety assessment of nanomaterials. Acc. Chem. Res. doi:10.1021/ar300020b (2012) (Epub ahead of print).
65. Prescott C. Regenerative nanomedicines: an emerging investment prospective? J. R. Soc. Inter. R. Soc. 7(Suppl. 6), S783-S787 (2010).
66. Arbab AS, Janic B, Haller J, Pawelczyk E, Liu W, Frank JA. In vivo cellular imaging for translational medical research. Curr. Med. Imaging Rev. 5(1), 19-38 (2009).
67. Gera A, Steinberg GK, Guzman R. In vivo neural stem cell imaging: current modalities and future directions. Regen. Med. 5(1), 73-86 (2010).
68. Ferreira L, Karp JM, Nobre L, Langer R. New opportunities: the use of nanotechnologies to manipulate and track stem cells. Cell Stem Cell 3(2), 136-146 (2008).
69. Thu MS, Bryant LH, Coppola T et al. Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nat. Med. 18(3), 463-467 (2012).
70. Lewin M, Carlesso N, Tung CH et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18(4), 410-414 (2000).
71. Terreno E, Castelli DD, Viale A, Aime S. Challenges for molecular magnetic resonance imaging. Chem. Rev. 110(5), 3019-3042 (2010).
72. Yu SB, Watson AD. Metal-based x-ray contrast media. Chem. Rev. 99(9), 2353-2378 (1999).
73. Chen K, Conti PS. Target-specifc delivery of peptide-based probes for PET imaging. Adv. Drug Del. Rev. 62(11), 1005-1022 (2010).
74. Reimer P, Balzer T. Ferucarbotran (Resovist): a new clinically approved RES-specifc contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur. Radiol. 13(6), 1266-1276 (2003).
75. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur. Radiol. 11(11), 2319-2331 (2001).
76. Hsiao JK, Tai MF, Chu HH et al. Magnetic nanoparticle labeling of mesenchymal stem cells without transfection agent: cellular behavior and capability of detection with clinical 5 T magnetic resonance at the single cell level. Magn. Reson. Med. 58(4), 717-724 (2007).
77. Arbab AS, Yocum GT, Kalish H et al. Effcient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104(4), 1217-1223 (2004).
78. Song YS, Ku JH. Monitoring transplanted human mesenchymal stem cells in rat and rabbit bladders using molecular magnetic resonance imaging. Neurourol. Urodynamics 26(4), 584-593 (2007).
79. Bruchez MP. Quantum dots fnd their stride in single molecule tracking. Curr. Opin Chem. Biol. 15(6), 775-780 (2011).
80. Lin S, Xie X, Patel MR et al. Quantum dot imaging for embryonic stem cells. BMC Biotechnol. 7, 67 (2007).
81. Zhang H, Yee D, Wang C. Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives. Nanomedicine (Lond.) 3(1), 83-91 (2008).
82. Alivisatos P. The use of nanocrystals in biological detection. Nat. Biotechnol. 22(1), 47-52 (2004).
83. Chen H, Titushkin I, Stroscio M, Cho M. Altered membrane dynamics of quantum dot-conjugated integrins during osteogenic differentiation of human bone marrow derived progenitor cells. Biophys. J. 92(4), 1399-1408 (2007).
84. Chakraborty SK, Fitzpatrick JA, Phillippi JA et al. Cholera toxin B conjugated quantum dots for live cell labeling. Nano Lett. 7(9), 2618-2626 (2007).
85. Shah BS, Mao JJ. Labeling of mesenchymal stem cells with bioconjugated quantum dots. Meth. Mol. Biol. 680, 61-75 (2011).
86. Slotkin JR, Chakrabarti L, Dai HN et al. In vivo quantum dot labeling of mammalian stem and progenitor cells. Dev. Dyn. 236(12), 3393-3401 (2007).
87. Hsieh SC, Wang FF, Lin CS, Chen YJ, Hung SC, Wang YJ. The inhibition of osteogenesis with human bone marrow mesenchymal stem cells by CdSe/ZnS quantum dot labels. Biomaterials 27(8), 1656-1664 (2006).
88. Maysinger D, Lovric J, Eisenberg A, Savic R. Fate of micelles and quantum dots in cells. Eur. J. Pharm. Biopharm. 65(3), 270-281 (2007).
89. Ruoslahti E, Bhatia SN, Sailor MJ. Targeting of drugs and nanoparticles to tumors. J. Cell Biol. 188(6), 759-768 (2010).
90. Mitsiadis TA, Rahiotis C. Parallels between tooth development and repair: conserved molecular mechanisms following carious and dental injury. J. Dental Res. 83(12), 896-902 (2004).
91. Derfus AM, Chen AA, Min DH, Ruoslahti E, Bhatia SN. Targeted quantum dot conjugates for siRNA delivery. Bioconjugate Chem. 18(5), 1391-1396 (2007).
92. Harris TJ, Green JJ, Fung PW, Langer R, Anderson DG, Bhatia SN. Tissue-specifc gene delivery via nanoparticle coating. Biomaterials 31(5), 998-1006 (2010).
93. Clements MO, Godfrey A, Crossley J, Wilson SJ, Takeuchi Y, Boshoff C. Lentiviral manipulation of gene expression in human adult and embryonic stem cells. Tissue Eng. 12 (7), 1741-1751 (2006).
94. Clements BA, Incani V, Kucharski C, Lavasanifar A, Ritchie B, Uludag H. A comparative evaluation of poly-L-lysine-palmitic acid and Lipofectamine 2000 for plasmid delivery to bone marrow stromal cells. Biomaterials 28 (31), 4693-4704 (2007).
95. Glover DJ, Lipps HJ, Jans DA. Towards safe, non-viral therapeutic gene expression in humans. Nat. Rev. Gene 6(4), 299-310 (2005).
96. Gropp M, Reubinoff B. Lentiviral vector-mediated gene delivery into human embryonic stem cells. Meth. Enzymol. 420, 64-81 (2006).
97. Aliabadi HM, Landry B, Sun C, Tang T, Uludag H. Supramolecular assemblies in functional siRNA delivery: where do we stand? Biomaterials 33(8), 2546-2569 (2012).
98. Bianco A, Kostarelos K, Prato M. Making carbon nanotubes biocompatible and biodegradable. Chem. Commun. (Camb.) 47(37), 10182-10188 (2011).
99. Kostarelos K. Carbon nanotubes: fbrillar pharmacology. Nat. Mater. 9(10), 793-795 (2010).
100. Kutsuzawa K, Akaike T, Chowdhury EH. The infuence of the cell-adhesive proteins E-cadherin and fbronectin embedded in carbonate-apatite DNA carrier on transgene delivery and expression in a mouse embryonic stem cell line. Biomaterials 29(3), 370-376 (2008).
101. Mooney DJ, Vandenburgh H. Cell delivery mechanisms for tissue repair. Cell Stem Cell 2(3), 205-213 (2008).
102. Kuo SW, Lin HI, Hui-Chun Ho J et al. Regulation of the fate of human mesenchymal stem cells by mechanical and stereo-topographical cues provided by silicon nanowires. Biomaterials 33(20), 5013-5022 (2012).
103. Shih YR, Chen CN, Tsai SW, Wang YJ, Lee OK. Growth of mesenchymal stem cells on electrospun type I collagen nanofbers. Stem Cells 24(11), 2391-2397 (2006).
104. Dzenis Y. Materials science. Structural nanocomposites. Science 319(5862), 419-420 (2008).
105. Murugan R, Ramakrishna S. Design strategies of tissue engineering scaffolds with controlled fber orientation. Tissue Eng. 13 (8), 1845-1866 (2007).
106. Mitsiadis TA, Barrandon O, Rochat A, Barrandon Y, De Bari C. Stem cell niches in mammals. Exp. Cell Res. 313(16), 3377-3385 (2007).
107. Kraehenbuehl TP, Langer R, Ferreira LS. Three-dimensional biomaterials for the study of human pluripotent stem cells. Nat. Methods 8(9), 731-736 (2011).
108. Dalby MJ, Andar A, Nag A et al. Genomic expression of mesenchymal stem cells to altered nanoscale topographies. J. R. Soc. Inter. R. Soc. 5(26), 1055-1065 (2008).
109. Dickinson LE, Kusuma S, Gerecht S. Reconstructing the differentiation niche of embryonic stem cells using biomaterials. Macromol. Biosci. 11(1), 36-49 (2011).
110. Lipski AM, Pino CJ, Haselton FR, Chen I W, Shastri V P. The effect of silica nanoparticle-modifed surfaces on cell morphology, cytoskeletal organization and function. Biomaterials 29(28), 3836-3846 (2008).
111. Hashi CK, Zhu Y, Yang GY et al. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofbrous vascular grafts. Proc. Natl Acad. Sci. USA 104(29), 11915-11920 (2007).
112. Hashi CK, Derugin N, Janairo RR et al. Antithrombogenic modifcation of small-diameter microfbrous vascular grafts. Arterioscler. Thromb. Vasc. Biol. 30(8), 1621-1627 (2010).